Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...

Carcinoid syndrome: This is caused by a carcinoid tumor, which is a type of neuroendocrine tumor. Carcinoid tumors release hormones into the bloodstream, causing symptoms such as flushing and sweating ...

This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

Patients with functional neuroendocrine tumors may experience hormone-related syndromes, such as carcinoid syndrome, characterized by flushing, diarrhea, and heart valve damage. 1 These syndromes ...

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs ... 1 adrenocorticotropin-producing tumor, and 1 carcinoid tumor diagnosed with diarrhea related to the pancreatic tumor. Among the 113 patients, ...

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor’s cancerous cells influence their surroundings, blocking the body’s immune defenses and creating a sort of haven ...

The final, formatted version of the article will be published soon. Ectopic adrenocorticotropic hormone secretion (EAS) is responsible for about 10-18% of Cushing`s syndrome cases. Thymic ...

Carcinoid syndrome is associated with fibrosis ... 1974 and 2008 using the following terms: “carcinoid”, “neuroendocrine tumors”, “fibrosis” and “5-hydroxytryptamine”.